HEADER VIRAL PROTEIN 22-JUL-16 5LKK TITLE PROTRUDING DOMAIN OF GII.17 NOROVIRUS KAWASAKI308 IN COMPLEX WITH 3- TITLE 2 FUCOSYLLACTOSE (3FL) COMPND MOL_ID: 1; COMPND 2 MOLECULE: MAJOR CAPSID PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: MAJOR VIRAL CAPSID PROTEIN; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: NOROVIRUS GII; SOURCE 3 ORGANISM_TAXID: 122929; SOURCE 4 GENE: VP1; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PLASMID KEYWDS NOROVIRUS, VIRUS CAPSID, HMOS, PROTRUDING DOMAIN, P DOMAIN, HUMAN KEYWDS 2 MILK OLIGOSACCHARIDES, VIRAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR B.K.SINGH,V.MOROZOV,G.S.HANSMAN REVDAT 3 10-JAN-24 5LKK 1 HETSYN LINK REVDAT 2 29-JUL-20 5LKK 1 COMPND REMARK HETNAM LINK REVDAT 2 2 1 SITE ATOM REVDAT 1 24-MAY-17 5LKK 0 JRNL AUTH B.K.SINGH,V.MOROZOV,G.S.HANSMAN JRNL TITL STRUCTURAL BASIS OF HMOS INTERACTION WITH THE EMERGING JRNL TITL 2 GII.17 NOROVIRUS KAWASAKI308 JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.49 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.49 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.90 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 3 NUMBER OF REFLECTIONS : 101853 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : 0.133 REMARK 3 R VALUE (WORKING SET) : 0.131 REMARK 3 FREE R VALUE : 0.164 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 5095 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4777 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 96 REMARK 3 SOLVENT ATOMS : 623 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 25.27 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.93 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): NULL REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.120 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5LKK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 22-JUL-16. REMARK 100 THE DEPOSITION ID IS D_1200000893. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-APR-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.96770 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 103757 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.480 REMARK 200 RESOLUTION RANGE LOW (A) : 48.900 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 200 DATA REDUNDANCY : 13.60 REMARK 200 R MERGE (I) : 0.07400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 20.8500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.48 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.52 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.3 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.79500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.5.6, PHASER REMARK 200 STARTING MODEL: 5FMO REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.11 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.28 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: MAGNESIUM CHLORIDE, PEG8000, TRIS-HCL, REMARK 280 PH 8.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 37.57000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 48.08500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 43.35500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 48.08500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 37.57000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 43.35500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6980 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23550 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 10.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 223 REMARK 465 VAL A 256 REMARK 465 LEU A 257 REMARK 465 VAL B 256 REMARK 465 LEU B 257 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 481 CG OD1 OD2 REMARK 470 ARG A 484 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 523 CG CD OE1 NE2 REMARK 470 GLN B 253 CG CD OE1 NE2 REMARK 470 ASN B 425 CG OD1 ND2 REMARK 470 ASP B 481 CG OD1 OD2 REMARK 470 ARG B 484 CG CD NE CZ NH1 NH2 REMARK 470 GLN B 523 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 910 O HOH A 997 2.17 REMARK 500 OD1 ASP A 343 O HOH A 701 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 896 O HOH A 923 3454 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 260 46.75 -151.59 REMARK 500 ALA A 344 57.13 38.68 REMARK 500 ASP A 518 -61.05 -101.91 REMARK 500 GLN B 260 46.39 -150.85 REMARK 500 VAL B 521 -151.40 -119.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1016 DISTANCE = 6.18 ANGSTROMS REMARK 525 HOH A1017 DISTANCE = 6.46 ANGSTROMS REMARK 525 HOH A1018 DISTANCE = 6.60 ANGSTROMS REMARK 525 HOH A1019 DISTANCE = 6.60 ANGSTROMS REMARK 525 HOH B1002 DISTANCE = 6.12 ANGSTROMS REMARK 525 HOH B1003 DISTANCE = 6.60 ANGSTROMS REMARK 525 HOH B1004 DISTANCE = 6.69 ANGSTROMS REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5FMO RELATED DB: PDB REMARK 900 PROTRUDING DOMAIN OF GII.17 NOROVIRUS KAWASAKI308 REMARK 900 RELATED ID: 5HZA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF GII.10 P DOMAIN IN COMPLEX WITH 3- REMARK 900 FUCOSYLLACTOSE (3 FL) REMARK 900 RELATED ID: 5J3O RELATED DB: PDB REMARK 900 PROTRUDING DOMAIN OF GII.4 HUMAN NOROVIRUS NSW0514 IN COMPLEX WITH REMARK 900 3-FUCOSYLLACTOSE (3FL) DBREF1 5LKK A 225 530 UNP A0A0S1Z370_9CALI DBREF2 5LKK A A0A0S1Z370 225 530 DBREF1 5LKK B 225 530 UNP A0A0S1Z370_9CALI DBREF2 5LKK B A0A0S1Z370 225 530 SEQADV 5LKK GLY A 223 UNP A0A0S1Z37 EXPRESSION TAG SEQADV 5LKK SER A 224 UNP A0A0S1Z37 EXPRESSION TAG SEQADV 5LKK GLY B 223 UNP A0A0S1Z37 EXPRESSION TAG SEQADV 5LKK SER B 224 UNP A0A0S1Z37 EXPRESSION TAG SEQRES 1 A 308 GLY SER LYS PRO PHE SER LEU PRO ILE LEU THR LEU SER SEQRES 2 A 308 GLU LEU THR ASN SER ARG PHE PRO VAL PRO ILE ASP SER SEQRES 3 A 308 LEU PHE THR ALA GLN ASN ASN VAL LEU GLN VAL GLN CYS SEQRES 4 A 308 GLN ASN GLY ARG CYS THR LEU ASP GLY GLU LEU GLN GLY SEQRES 5 A 308 THR THR GLN LEU LEU PRO THR GLY ILE CYS ALA PHE ARG SEQRES 6 A 308 GLY ARG VAL THR ALA GLN ILE ASN GLN ARG ASP ARG TRP SEQRES 7 A 308 HIS MET GLN LEU GLN ASN LEU ASN GLY THR THR TYR ASP SEQRES 8 A 308 PRO THR ASP ASP VAL PRO ALA PRO LEU GLY THR PRO ASP SEQRES 9 A 308 PHE LYS GLY VAL VAL PHE GLY MET VAL SER GLN ARG ASN SEQRES 10 A 308 VAL GLY ASN ASP ALA PRO GLY SER THR ARG ALA GLN GLN SEQRES 11 A 308 ALA TRP VAL SER THR TYR SER PRO GLN PHE VAL PRO LYS SEQRES 12 A 308 LEU GLY SER VAL ASN LEU ARG ILE SER ASP ASN ASP ASP SEQRES 13 A 308 PHE GLN PHE GLN PRO THR LYS PHE THR PRO VAL GLY VAL SEQRES 14 A 308 ASN ASP ASP ASP ASP GLY HIS PRO PHE ARG GLN TRP GLU SEQRES 15 A 308 LEU PRO ASN TYR SER GLY GLU LEU THR LEU ASN MET ASN SEQRES 16 A 308 LEU ALA PRO PRO VAL ALA PRO ASN PHE PRO GLY GLU GLN SEQRES 17 A 308 LEU LEU PHE PHE ARG SER PHE VAL PRO CYS SER GLY GLY SEQRES 18 A 308 TYR ASN GLN GLY ILE ILE ASP CYS LEU ILE PRO GLN GLU SEQRES 19 A 308 TRP ILE GLN HIS PHE TYR GLN GLU SER ALA PRO SER GLN SEQRES 20 A 308 SER ASP VAL ALA LEU ILE ARG TYR VAL ASN PRO ASP THR SEQRES 21 A 308 GLY ARG THR LEU PHE GLU ALA LYS LEU HIS ARG SER GLY SEQRES 22 A 308 TYR ILE THR VAL ALA HIS SER GLY ASP TYR PRO LEU VAL SEQRES 23 A 308 VAL PRO ALA ASN GLY HIS PHE ARG PHE ASP SER TRP VAL SEQRES 24 A 308 ASN GLN PHE TYR SER LEU ALA PRO MET SEQRES 1 B 308 GLY SER LYS PRO PHE SER LEU PRO ILE LEU THR LEU SER SEQRES 2 B 308 GLU LEU THR ASN SER ARG PHE PRO VAL PRO ILE ASP SER SEQRES 3 B 308 LEU PHE THR ALA GLN ASN ASN VAL LEU GLN VAL GLN CYS SEQRES 4 B 308 GLN ASN GLY ARG CYS THR LEU ASP GLY GLU LEU GLN GLY SEQRES 5 B 308 THR THR GLN LEU LEU PRO THR GLY ILE CYS ALA PHE ARG SEQRES 6 B 308 GLY ARG VAL THR ALA GLN ILE ASN GLN ARG ASP ARG TRP SEQRES 7 B 308 HIS MET GLN LEU GLN ASN LEU ASN GLY THR THR TYR ASP SEQRES 8 B 308 PRO THR ASP ASP VAL PRO ALA PRO LEU GLY THR PRO ASP SEQRES 9 B 308 PHE LYS GLY VAL VAL PHE GLY MET VAL SER GLN ARG ASN SEQRES 10 B 308 VAL GLY ASN ASP ALA PRO GLY SER THR ARG ALA GLN GLN SEQRES 11 B 308 ALA TRP VAL SER THR TYR SER PRO GLN PHE VAL PRO LYS SEQRES 12 B 308 LEU GLY SER VAL ASN LEU ARG ILE SER ASP ASN ASP ASP SEQRES 13 B 308 PHE GLN PHE GLN PRO THR LYS PHE THR PRO VAL GLY VAL SEQRES 14 B 308 ASN ASP ASP ASP ASP GLY HIS PRO PHE ARG GLN TRP GLU SEQRES 15 B 308 LEU PRO ASN TYR SER GLY GLU LEU THR LEU ASN MET ASN SEQRES 16 B 308 LEU ALA PRO PRO VAL ALA PRO ASN PHE PRO GLY GLU GLN SEQRES 17 B 308 LEU LEU PHE PHE ARG SER PHE VAL PRO CYS SER GLY GLY SEQRES 18 B 308 TYR ASN GLN GLY ILE ILE ASP CYS LEU ILE PRO GLN GLU SEQRES 19 B 308 TRP ILE GLN HIS PHE TYR GLN GLU SER ALA PRO SER GLN SEQRES 20 B 308 SER ASP VAL ALA LEU ILE ARG TYR VAL ASN PRO ASP THR SEQRES 21 B 308 GLY ARG THR LEU PHE GLU ALA LYS LEU HIS ARG SER GLY SEQRES 22 B 308 TYR ILE THR VAL ALA HIS SER GLY ASP TYR PRO LEU VAL SEQRES 23 B 308 VAL PRO ALA ASN GLY HIS PHE ARG PHE ASP SER TRP VAL SEQRES 24 B 308 ASN GLN PHE TYR SER LEU ALA PRO MET HET GLC C 1 12 HET FUC C 2 10 HET GAL C 3 11 HET GLC D 1 12 HET FUC D 2 10 HET GAL D 3 11 HET EDO A 601 4 HET EDO A 602 4 HET EDO A 603 4 HET EDO A 604 4 HET MG A 605 1 HET EDO B 601 4 HET EDO B 602 4 HET EDO B 603 4 HET MG B 604 1 HETNAM GLC ALPHA-D-GLUCOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETNAM GAL BETA-D-GALACTOPYRANOSE HETNAM EDO 1,2-ETHANEDIOL HETNAM MG MAGNESIUM ION HETSYN GLC ALPHA-D-GLUCOSE; D-GLUCOSE; GLUCOSE HETSYN FUC ALPHA-L-FUCOSE; 6-DEOXY-ALPHA-L-GALACTOPYRANOSE; L- HETSYN 2 FUC FUCOSE; FUCOSE HETSYN GAL BETA-D-GALACTOSE; D-GALACTOSE; GALACTOSE HETSYN EDO ETHYLENE GLYCOL FORMUL 3 GLC 2(C6 H12 O6) FORMUL 3 FUC 2(C6 H12 O5) FORMUL 3 GAL 2(C6 H12 O6) FORMUL 5 EDO 7(C2 H6 O2) FORMUL 9 MG 2(MG 2+) FORMUL 14 HOH *623(H2 O) HELIX 1 AA1 THR A 233 LEU A 237 5 5 HELIX 2 AA2 LEU A 279 ILE A 283 5 5 HELIX 3 AA3 PRO A 454 SER A 465 1 12 HELIX 4 AA4 THR B 233 LEU B 237 5 5 HELIX 5 AA5 LEU B 279 ILE B 283 5 5 HELIX 6 AA6 PRO B 454 SER B 465 1 12 SHEET 1 AA1 4 ILE A 448 CYS A 451 0 SHEET 2 AA1 4 GLU A 429 PHE A 437 -1 N PHE A 434 O CYS A 451 SHEET 3 AA1 4 SER A 248 THR A 251 -1 N PHE A 250 O PHE A 433 SHEET 4 AA1 4 TYR A 505 PRO A 506 -1 O TYR A 505 N THR A 251 SHEET 1 AA2 6 ILE A 448 CYS A 451 0 SHEET 2 AA2 6 GLU A 429 PHE A 437 -1 N PHE A 434 O CYS A 451 SHEET 3 AA2 6 TYR A 496 ALA A 500 -1 O VAL A 499 N GLN A 430 SHEET 4 AA2 6 THR A 485 HIS A 492 -1 N HIS A 492 O TYR A 496 SHEET 5 AA2 6 VAL A 472 VAL A 478 -1 N ALA A 473 O LEU A 491 SHEET 6 AA2 6 HIS A 514 VAL A 521 -1 O SER A 519 N LEU A 474 SHEET 1 AA3 7 PHE A 286 GLN A 293 0 SHEET 2 AA3 7 TRP A 300 GLN A 305 -1 O GLN A 305 N ARG A 287 SHEET 3 AA3 7 SER A 368 ILE A 373 -1 O VAL A 369 N MET A 302 SHEET 4 AA3 7 THR A 348 SER A 356 -1 N TRP A 354 O ARG A 372 SHEET 5 AA3 7 VAL A 330 ARG A 338 -1 N VAL A 331 O VAL A 355 SHEET 6 AA3 7 PRO A 383 ASN A 392 -1 O THR A 387 N MET A 334 SHEET 7 AA3 7 PHE A 286 GLN A 293 -1 N PHE A 286 O PHE A 386 SHEET 1 AA4 4 ILE B 448 CYS B 451 0 SHEET 2 AA4 4 GLU B 429 PHE B 437 -1 N PHE B 434 O CYS B 451 SHEET 3 AA4 4 SER B 248 THR B 251 -1 N PHE B 250 O PHE B 433 SHEET 4 AA4 4 TYR B 505 PRO B 506 -1 O TYR B 505 N THR B 251 SHEET 1 AA5 6 ILE B 448 CYS B 451 0 SHEET 2 AA5 6 GLU B 429 PHE B 437 -1 N PHE B 434 O CYS B 451 SHEET 3 AA5 6 TYR B 496 ALA B 500 -1 O VAL B 499 N GLN B 430 SHEET 4 AA5 6 THR B 485 HIS B 492 -1 N HIS B 492 O TYR B 496 SHEET 5 AA5 6 VAL B 472 VAL B 478 -1 N ALA B 473 O LEU B 491 SHEET 6 AA5 6 HIS B 514 VAL B 521 -1 O SER B 519 N LEU B 474 SHEET 1 AA6 7 PHE B 286 GLN B 293 0 SHEET 2 AA6 7 TRP B 300 GLN B 305 -1 O GLN B 305 N ARG B 287 SHEET 3 AA6 7 SER B 368 ILE B 373 -1 O VAL B 369 N MET B 302 SHEET 4 AA6 7 THR B 348 SER B 356 -1 N TRP B 354 O ARG B 372 SHEET 5 AA6 7 VAL B 330 ARG B 338 -1 N VAL B 331 O VAL B 355 SHEET 6 AA6 7 PRO B 383 ASN B 392 -1 O VAL B 389 N PHE B 332 SHEET 7 AA6 7 PHE B 286 GLN B 293 -1 N PHE B 286 O PHE B 386 LINK O3 GLC C 1 C1 FUC C 2 1555 1555 1.43 LINK O4 GLC C 1 C1 GAL C 3 1555 1555 1.42 LINK O3 GLC D 1 C1 FUC D 2 1555 1555 1.43 LINK O4 GLC D 1 C1 GAL D 3 1555 1555 1.40 CRYST1 75.140 86.710 96.170 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013308 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011533 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010398 0.00000